Cocrystal Pharma Book Value Per Share Growth & History (COCP)
Cocrystal Pharma's book value per share was $0.46 for fiscal 2025.
View full Cocrystal Pharma company overviewCocrystal Pharma annual book value per share history
| Fiscal year | Period ended | Book value per share | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $0.46 | -$0.48 | −50.93% |
| 2024 | 2024-12-31 | $0.94 | -$1.66 | −63.91% |
| 2023 | 2023-12-31 | $2.59 | -$2.27 | −46.67% |
| 2022 | 2022-12-31 | $4.86 | -$4.66 | −48.94% |
| 2021 | 2021-12-31 | $9.52 | $0.58 | +6.47% |
| 2020 | 2020-12-31 | $8.94 | $0.17 | +1.92% |
| 2019 | 2019-12-31 | $8.78 | -$18.03 | −67.26% |
| 2018 | 2018-12-31 | $26.81 | -$25.29 | −48.54% |
| 2017 | 2017-12-31 | $52.10 | $0.52 | +1.00% |
| 2016 | 2016-12-31 | $51.59 | -$35.30 | −40.63% |
| 2015 | 2015-12-31 | $86.89 | $67.34 | +344.51% |
| 2014 | 2014-12-31 | $19.55 | $79.39 | — |
| 2013 | 2013-12-31 | -$59.85 | -$31.29 | — |
| 2012 | 2012-12-31 | -$28.55 | -$10.49 | — |
| 2011 | 2011-12-31 | -$18.07 | -$13.33 | — |
| 2010 | 2010-12-31 | -$4.74 | — | — |
Cocrystal Pharma quarterly book value per share
| Fiscal quarter | Period ended | Book value per share | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $0.08 | -$0.45 | −85.56% |
| Q1 2026 | 2026-03-31 | $0.30 | -$0.42 | −58.42% |
| Q4 2025 | 2025-12-31 | $0.46 | -$0.48 | −50.93% |
| Q3 2025 | 2025-09-30 | $0.59 | -$0.66 | −52.90% |
| Q2 2025 | 2025-06-30 | $0.52 | -$1.19 | −69.33% |
| Q1 2025 | 2025-03-31 | $0.72 | -$1.50 | −67.66% |
| Q4 2024 | 2024-12-31 | $0.94 | -$1.66 | −63.91% |
| Q3 2024 | 2024-09-30 | $1.25 | -$1.77 | −58.61% |
| Q2 2024 | 2024-06-30 | $1.71 | -$1.70 | −49.86% |
| Q1 2024 | 2024-03-31 | $2.22 | -$2.04 | −47.86% |
| Q4 2023 | 2023-12-31 | $2.59 | -$2.27 | −46.67% |
| Q3 2023 | 2023-09-30 | $3.02 | -$3.11 | −50.78% |
| Q2 2023 | 2023-06-30 | $3.41 | -$2.67 | −43.94% |
| Q1 2023 | 2023-03-31 | $4.26 | -$4.80 | −53.00% |
| Q4 2022 | 2022-12-31 | $4.86 | -$4.66 | −48.94% |
| Q3 2022 | 2022-09-30 | $6.13 | -$3.84 | −38.55% |
| Q2 2022 | 2022-06-30 | $6.08 | -$4.35 | −41.72% |
| Q1 2022 | 2022-03-31 | $9.06 | $0.32 | +3.64% |
| Q4 2021 | 2021-12-31 | $9.52 | $0.58 | +6.47% |
| Q3 2021 | 2021-09-30 | $9.97 | $1.19 | +13.57% |
| Q2 2021 | 2021-06-30 | $10.43 | $1.91 | +22.35% |
| Q1 2021 | 2021-03-31 | $8.74 | -$0.56 | −6.06% |
| Q4 2020 | 2020-12-31 | $8.94 | $0.17 | +1.92% |
| Q3 2020 | 2020-09-30 | $8.78 | -$18.07 | −67.29% |
| Q2 2020 | 2020-06-30 | $8.53 | -$18.95 | −68.97% |
| Q1 2020 | 2020-03-31 | $9.30 | -$18.71 | −66.79% |
| Q4 2019 | 2019-12-31 | $8.78 | -$18.03 | −67.26% |
| Q3 2019 | 2019-09-30 | $26.85 | -$17.63 | −39.63% |
| Q2 2019 | 2019-06-30 | $27.48 | -$17.69 | −39.17% |
| Q1 2019 | 2019-03-31 | $28.02 | -$23.20 | −45.29% |
| Q4 2018 | 2018-12-31 | $26.81 | -$25.29 | −48.54% |
| Q3 2018 | 2018-09-30 | $44.47 | -$4.96 | −10.03% |
| Q2 2018 | 2018-06-30 | $45.18 | -$5.38 | −10.65% |
| Q1 2018 | 2018-03-31 | $51.21 | $0.80 | +1.59% |
| Q4 2017 | 2017-12-31 | $52.10 | $0.52 | +1.00% |
| Q3 2017 | 2017-09-30 | $49.43 | -$35.18 | −41.58% |
| Q2 2017 | 2017-06-30 | $50.56 | -$34.72 | −40.71% |
| Q1 2017 | 2017-03-31 | $50.41 | -$36.16 | −41.77% |
| Q4 2016 | 2016-12-31 | $51.59 | -$35.30 | −40.63% |
| Q3 2016 | 2016-09-30 | $84.61 | -$17.39 | −17.05% |
| Q2 2016 | 2016-06-30 | $85.28 | -$16.61 | −16.30% |
| Q1 2016 | 2016-03-31 | $86.56 | -$12.28 | −12.43% |
| Q4 2015 | 2015-12-31 | $86.89 | $67.34 | +344.51% |
| Q3 2015 | 2015-09-30 | $102.01 | $90.32 | +772.52% |
| Q2 2015 | 2015-06-30 | $101.89 | $84.00 | +469.62% |
| Q1 2015 | 2015-03-31 | $98.85 | $104.99 | — |
| Q4 2014 | 2014-12-31 | $19.55 | $79.39 | — |
| Q3 2014 | 2014-09-30 | $11.69 | $65.37 | — |
| Q2 2014 | 2014-06-30 | $17.89 | $45.32 | — |
| Q1 2014 | 2014-03-31 | -$6.14 | $22.69 | — |
| Q4 2013 | 2013-12-31 | -$59.85 | -$31.29 | — |
| Q3 2013 | 2013-09-30 | -$53.68 | -$53.25 | — |
| Q2 2013 | 2013-06-30 | -$27.43 | -$4.59 | — |
| Q1 2013 | 2013-03-31 | -$28.83 | $7.63 | — |
| Q4 2012 | 2012-12-31 | -$28.55 | -$10.49 | — |
| Q3 2012 | 2012-09-30 | -$0.43 | $0.52 | — |
| Q2 2012 | 2012-06-30 | -$22.84 | -$24.81 | — |
| Q1 2012 | 2012-03-31 | -$36.45 | — | — |
| Q4 2011 | 2011-12-31 | -$18.07 | -$13.47 | — |
| Q3 2011 | 2011-09-30 | -$0.95 | — | — |
| Q2 2011 | 2011-06-30 | $1.97 | — | — |
| Q4 2010 | 2010-12-31 | -$4.59 | — | — |
Cocrystal Pharma book value per share trends
Over the last five fiscal years, Cocrystal Pharma's book value per share decreased from $8.94 to $0.46, a change of -$8.49. The latest reported quarter, Q2 2026, shows $0.08.
What book value per share means
Book value per share estimates the common shareholders’ accounting equity represented by each share. It can help compare a company’s balance-sheet value over time, although market value can differ substantially from book value.
How book value per share is calculated
TickerStat calculates book value per share as SEC-reported common shareholders’ equity divided by reported period-end common shares. Preferred equity is subtracted when separately reported, and basic weighted-average shares are used only when period-end shares are unavailable. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cocrystal Pharma source filings ↗